TY - JOUR
T1 - In Vitro Fertilization and Risk for Hypertensive Disorders of Pregnancy
T2 - Associations with Treatment Parameters
AU - Luke, Barbara
AU - Brown, Morton B.
AU - Eisenberg, Michael L.
AU - Callan, Caitriona
AU - Botting, Beverley J.
AU - Pacey, Allan
AU - Sutcliffe, Alastair G.
AU - Baker, Valerie L.
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - (Abstracted from Am J Obstet Gynecol 2020;222:350.e1-350.e13) With an increasing proportion of pregnancies being conceived using assisted-reproductive technology, important changes to in vitro fertilization (IVF) such as the use of cryopreserved oocytes or embryos have been made. It is now established that adverse maternal and infant perinatal outcomes are associated with both assisted reproductive technologies and subfertility.
AB - (Abstracted from Am J Obstet Gynecol 2020;222:350.e1-350.e13) With an increasing proportion of pregnancies being conceived using assisted-reproductive technology, important changes to in vitro fertilization (IVF) such as the use of cryopreserved oocytes or embryos have been made. It is now established that adverse maternal and infant perinatal outcomes are associated with both assisted reproductive technologies and subfertility.
UR - http://www.scopus.com/inward/record.url?scp=85096006410&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096006410&partnerID=8YFLogxK
U2 - 10.1097/OGX.0000000000000852
DO - 10.1097/OGX.0000000000000852
M3 - Comment/debate
AN - SCOPUS:85096006410
SN - 0029-7828
VL - 75
SP - 608
EP - 609
JO - Obstetrical and Gynecological Survey
JF - Obstetrical and Gynecological Survey
IS - 10
ER -